Advertisement
Screener

Corvus Pharmaceuticals, Inc. (CRVS) Other

Corvus Pharmaceuticals, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2025-03-25: Form 10-K; Item Well-known seasoned issuer; As filed No.
  • 2024-03-19: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock · CRVS · Nasdaq Global Market.
  • 2024-03-19: Form 10-K; Item Well-known seasoned issuer; As filed No.
  • 2023-11-07: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · CRVS · Nasdaq Global Market.
FiledFormItemAs filed
2025-03-2510-KWell-known seasoned issuerNo
2024-03-1910-KStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2024-03-1910-KWell-known seasoned issuerNo
2023-11-0710-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2023-08-0810-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2023-05-0810-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2023-03-2810-KStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2023-03-2810-KWell-known seasoned issuerNo
2022-11-0310-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2022-08-0810-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2022-05-0510-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2022-03-1010-KStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2022-03-1010-KWell-known seasoned issuerNo
2021-11-0110-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2021-11-0110-QEmerging growth companyYes
2021-08-0210-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2021-08-0210-QEmerging growth companyYes
2021-04-2910-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2021-04-2910-QEmerging growth companyYes
2021-03-2510-KStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2021-03-2510-KEmerging growth companyYes
2021-03-2510-KWell-known seasoned issuerNo
2020-10-2910-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2020-10-2910-QEmerging growth companyYes
2020-07-3010-QStock registered under Section 12(b)Common Stock · CRVS · Nasdaq Global Market
2020-07-3010-QEmerging growth companyYes
2020-04-3010-QEmerging growth companyYes
2020-03-0910-KEmerging growth companyYes
2020-03-0910-KWell-known seasoned issuerNo
2019-10-2910-QEmerging growth companyYes
2019-08-0110-QEmerging growth companyYes
2019-05-0910-QEmerging growth companyYes
2019-03-0710-KEmerging growth companyYes
2019-03-0710-KWell-known seasoned issuerNo
2018-11-0110-QEmerging growth companyYes
2018-05-0310-QWell-known seasoned issuerNo
2018-03-0110-KWell-known seasoned issuerNo
2017-03-1010-KWell-known seasoned issuerNo
2016-08-0410-QCurrent in its reportingNo
2016-05-0510-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Apnimed, Inc. (APMD)United States$0.899B